AQR Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

AQR Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,195	Closed	-$94K	–	2349
2018 Q2	$94K	Sell	5,195 -11,793	-69%	-$174K	﹤0.01%	2293
2018 Q1	$181K	Sell	16,988 -2,263	-12%	-$36.4K	﹤0.01%	2159
2017 Q4	$812K	Sell	19,251 -1,486	-7%	-$66.7K	﹤0.01%	1745
2017 Q3	$1.14M	Buy	20,737 +14,552	+235%	+$2.45M	﹤0.01%	1621
2017 Q2	$1.15M	Buy	+6,185	New	+$1.08M	﹤0.01%	1622
2017 Q1	–	Sell	-1,399	Closed	-$139K	–	2270
2016 Q4	$139K	Buy	+1,399	New	+$147K	﹤0.01%	2191

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AQR Capital Management's SIOX Position: Q3 2018 in Review

AQR Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2018, closing a stake of 5,195 shares — an estimated $94K sold.

AQR Capital Management first reported a position in SIOX in Q4 2016 and held it in 6 quarters. The position peaked at $1.15M in Q2 2017. 61 funds tracked by Wall St. Rank hold SIOX as of Q3 2018.

AQR Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
AQR Capital Management sold 5,195 Sio Gene Therapies Inc. Common Stock shares in Q3 2018, an estimated $94K.
AQR Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 6 quarters.
AQR Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $1.15M in Q2 2017.
61 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2018.

Based on AQR Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.